Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-013063
Filing Date
2025-02-12
Accepted
2025-02-12 17:30:47
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0228900-10q_inmed.htm   iXBRL 10-Q 1117484
2 CERTIFICATION ea022890001ex31-1_inmed.htm EX-31.1 11694
3 CERTIFICATION ea022890001ex31-2_inmed.htm EX-31.2 11788
4 CERTIFICATION ea022890001ex32-1_inmed.htm EX-32.1 4235
5 CERTIFICATION ea022890001ex32-2_inmed.htm EX-32.2 4271
11 GRAPHIC image_001.jpg GRAPHIC 11723
12 GRAPHIC image_002.jpg GRAPHIC 11723
  Complete submission text file 0001213900-25-013063.txt   5956581

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20241231.xsd EX-101.SCH 41538
7 XBRL CALCULATION FILE inm-20241231_cal.xml EX-101.CAL 44487
8 XBRL DEFINITION FILE inm-20241231_def.xml EX-101.DEF 209556
9 XBRL LABEL FILE inm-20241231_lab.xml EX-101.LAB 405140
10 XBRL PRESENTATION FILE inm-20241231_pre.xml EX-101.PRE 229295
78 EXTRACTED XBRL INSTANCE DOCUMENT ea0228900-10q_inmed_htm.xml XML 877677
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 25616219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)